Here in our news overview you will find all articles from the RESIST online editorial team. Of course we appreciate your interest in our work – and also when you share our news in social media.<\/p>\n<\/div>
Since the beginning of RESIST\u2019s second funding phase in early 2026, Prof. Dr. Thomas Skripuletz has been part of the research consortium. The neurologist has headed the Laboratory for [...]<\/a><\/p><\/div> Since the beginning of RESIST\u2019s second funding phase in early 2026, Prof. Dr. Thomas Skripuletz has been part of the research consortium. The neurologist has headed the Laboratory for [...]<\/a><\/p><\/div> Since the beginning of RESIST\u2019s second funding phase in early 2026, Prof. Dr. Thomas Skripuletz has been part of the research consortium. The neurologist has headed the Laboratory for Cerebrospinal Fluid Diagnostics and Neurochemistry at Hannover Medical School since 2021 and contributes extensive expertise in the study of neuroimmunological [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>UniStemDay 2026: Students Experience Cutting-Edge Research Up Close at MHH<\/h2><\/div>March 31, 2026<\/h4><\/div>March 31, 2026<\/h4><\/div>March 31, 2026<\/h4><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The event, held in Germany since 2016 and now organized worldwide, brought together over 35,000 participants this year across more than [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>First Orientation Event for YOUNG RESIST and Elections for the YOUNG RESIST Board<\/h2><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Since the beginning of RESIST\u2019s second funding phase in early 2026, Prof. Dr. Thomas Skripuletz has been part of the research consortium. The neurologist has headed the Laboratory for [...]<\/a><\/p><\/div> Since the beginning of RESIST\u2019s second funding phase in early 2026, Prof. Dr. Thomas Skripuletz has been part of the research consortium. The neurologist has headed the Laboratory for Cerebrospinal Fluid Diagnostics and Neurochemistry at Hannover Medical School since 2021 and contributes extensive expertise in the study of neuroimmunological [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>UniStemDay 2026: Students Experience Cutting-Edge Research Up Close at MHH<\/h2><\/div>March 31, 2026<\/h4><\/div>March 31, 2026<\/h4><\/div>March 31, 2026<\/h4><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The event, held in Germany since 2016 and now organized worldwide, brought together over 35,000 participants this year across more than [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>First Orientation Event for YOUNG RESIST and Elections for the YOUNG RESIST Board<\/h2><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Since the beginning of RESIST\u2019s second funding phase in early 2026, Prof. Dr. Thomas Skripuletz has been part of the research consortium. The neurologist has headed the Laboratory for Cerebrospinal Fluid Diagnostics and Neurochemistry at Hannover Medical School since 2021 and contributes extensive expertise in the study of neuroimmunological [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>UniStemDay 2026: Students Experience Cutting-Edge Research Up Close at MHH<\/h2><\/div>March 31, 2026<\/h4><\/div>March 31, 2026<\/h4><\/div>March 31, 2026<\/h4><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The event, held in Germany since 2016 and now organized worldwide, brought together over 35,000 participants this year across more than [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>First Orientation Event for YOUNG RESIST and Elections for the YOUNG RESIST Board<\/h2><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The event, held in Germany since 2016 and now organized worldwide, brought together over 35,000 participants this year across more than [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>First Orientation Event for YOUNG RESIST and Elections for the YOUNG RESIST Board<\/h2><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The [...]<\/a><\/p><\/div> The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The event, held in Germany since 2016 and now organized worldwide, brought together over 35,000 participants this year across more than [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>First Orientation Event for YOUNG RESIST and Elections for the YOUNG RESIST Board<\/h2><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The event, held in Germany since 2016 and now organized worldwide, brought together over 35,000 participants this year across more than [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>First Orientation Event for YOUNG RESIST and Elections for the YOUNG RESIST Board<\/h2><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div>March 17, 2026<\/h4><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST [...]<\/a><\/p><\/div> On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Dr. Lennart Riemann awarded “Infection Biology PhD Prize”<\/h2><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div>March 10, 2026<\/h4><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for [...]<\/a><\/p><\/div> Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Dr. Lennart Riemann (PhD) has been awarded the Infection Biology PhD Prize, supported by RESIST and endowed with \u20ac1,000. The prize recognizes his dissertation entitled \"Systems Immunology Approaches for Human Immune Profiling in Vaccination and Aging,\" in which he investigated modern systems immunology methods for analyzing human immune responses. [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Precision Medicine for the Liver<\/h2><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div>February 17, 2026<\/h4><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by [...]<\/a><\/p><\/div> RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease \"primary sclerosing cholangitis (PSC)\" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>How does Long COVID develop? A new piece of the puzzle identified<\/h2><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div>February 12, 2026<\/h4><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li [...]<\/a><\/p><\/div> Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>Researchers develop new approaches to treating chronic wounds<\/h2><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div>February 9, 2026<\/h4><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are [...]<\/a><\/p><\/div> At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>The new newsletter is here<\/h2><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div>December 15, 2025<\/h4><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students [...]<\/a><\/p><\/div> Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>
Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).\u00a0 You can join us as we explain to school pupils, patients and interested guests at the MHH [...]<\/a><\/p><\/div><\/div><\/li>\n<\/span><\/a><\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div>RESIST in the podcast<\/h2><\/div>